日本大学医学部 放射線医学系 2017年度研究実績
| 2020年度 | 2019年度 | 2018年度 |
| 2017年度 | 2016年度 | 2015年度 |
| 2014年度 | 2013年度 | 2012年度 |
| 2011年度 | 2010年度 | 2009年度 |
| 2008年度 | 2007年度 | 2006年度 |
Ⅰ．論 文
１．原著・症例報告
1. Nakachi S, Okada M, Morishima S, Agarie Y, Kitamura S, Uchibori S, Tomori S, Hanashiro T, Shimabukuro N, Tamaki K, Tedokon I, Morichika K, Nishi Y, Tomoyose T, Karube K, Fukushima T, Murayama S, Masuzaki H. Clinical Usefulness of FDG-PET/CT for the Evaluation of Various Types of Adult T-Cell Leukemia. Hematology 2017;22(9):536-543. [IF:1.315]
2. Kumamaru KK, Murayama S, Yamashita Y, Nojo T, Watanabe Y, Goto M, Maeda E, Echigo J, Soga S, Fujii S, Tanami Y, Okabe T, Okada M, Munechika J, Ota H, Miyake M, Honda H, Aoki S. Appropriate Imaging Utilization in Japan: A Survey of Accredited Radiology Training Hospitals. Japanese Journal of Radiology 2017;35(11):648-654. [IF:1.044]
3. Mitsuka Y, Midorikawa Y, Abe H, Matsumoto N, Moriyama M, Haradome H, Sugitani M, Tsuji S, Takayama T. A prediction model for the grade of liver fibrosis using magnetic resonance elastography. BMC Gastroenterology 2017;17(1):133. [IF:2.731]
4. Haradome H, Unno T, Morisaka H, Toda Y, Kwee TC, Kondo H, Sano K, Ichikawa T, Kondo F, Sugitani M, Takayama T. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations. European Radiology 2017;27(11):4461-4471. [IF:4.027]
5. Abe H, Midorikawa Y, Mitsuka Y, Aramaki O, Higaki T, Matsumoto N, Moriyama M, Haradome H, Abe O, Sugitani M, Tsuji S, Takayama T. Predicting postoperative outcomes of liver resection by magnetic resonance elastography. Surgery 2017;162(2):248-255. [IF:3.574]
6. Nishie A, Goshima S, Haradome H, Hatano E, Imai Y, Kudo M, Matsuda M, Motosugi U, Saitoh S, Yoshimitsu K, Crawford B, Kruger E, Ball G10, Honda H. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan. Clinical Therapeutics 2017;39(4):738-750.e4. [IF:3.185]
7. Wada A, Shizukuishi T, Kikuta J, Yamada H, Watanabe Y, Imamura Y, Shinozaki T, Dezawa K, Haradome H, Abe O. Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography. Neuroradiology 2017;59(5):525-532. [IF:2.346]
8. Haradome H, Okubo T, Toda Y, Woo J, Takayama T, Abe O. Shrunken Hepatic Hemangioma Following Delineated Peritumoral Hyperintensity on Gadoxetic Acid Disodium-enhanced MR Imaging. Magnetic Resonance in Medical Sciences 2017;16(4):271-272. [IF:1.455]
9. Amano Y, Yanagisawa F, Tachi M, Hashimoto H, Imai S, Kumita S. Myocardial T2 mapping in patients with hypertrophic cardiomyopathy. Journal of Computer Assisted Tomography 2017;41(3):344-348. [IF:1.292]
10. Kitamura M, Amano Y, Takayama M, Shibuya J, Matsuda J, Sangen H, Nakamura S, Takano H, Asai K, Kumita S, Shimizu W. Usefulness of non-anteroseptal region left ventricular hypertrophy using cardiac magnetic resonance to predict repeat alcohol septal ablation for refractory obstructive hypertrophic cardiomyopathy. American Journal of Cardiology 2017;120(1):124-130. [IF:3.171]
11. Amano Y, Woo J, Amano M, Yanagisawa F, Yamamoto H, Tani M. MRI texture analysis of background parenchymal enhancement of the breast. BioMed Research International 2017;2017:4845909. [IF:2.583]
12. Amano Y, Yanagisawa F, Kitamura M, Tachi M, Kumita S. Relationship of non-septal late gadolinium enhancement to ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Journal of Computer Assisted Tomography 2017;41:768-771. [IF:1.292]
13. Aoyama R, Takano H, Kobayashi Y, Kitamura M, Asai K, Amano Y, Kumita SI, Shimizu W. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography. PLoS One 2017;12(11):e0188479. [IF:2.766]
14. Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Amano Y. Vaginal tumor-vesical fistula detected by dynamic fluorodeoxyglucose-positron emission tomography/computed tomography: a case report. Clinical Imaging 2017;46:113-115. [IF:1.014]
15. Amano Y, Yanagisawa F, Tachi M, Asai K, Suzuki Y, Hashimoto H, Ishihara K, Kumita S. Three-dimensional Cardiac MR Imaging: Related Techniques and Clinical Applications. Magnetic Resonance in Medical Sciences 2017;16(3):183-189. [IF:1.455]
16. Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Sato T, Kawamori J, Tanaka Y. Treatment outcomes of concurrent hyperthermia and chemoradiotherapy for pancreatic cancer: Insights into the significance of hyperthermia treatment. Oncology Letters 2017;13(6):4959-4964. [IF:1.664]
17. Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Taku H, Ohhara M, Takimoto T, Tanaka Y. A long-surviving patient with advanced esophageal basaloid squamous cell carcinoma treated only with radiotherapy: case report and literature review. BMC Gastroenterology 2017;17(1):151. [IF:2.731]
18. Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Sato H, Sato K, Matsui T, Yamaguchi K, Takahashi S. Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer. Chinese Medical Journal 2017;130(20):2441-2446. [IF:1.596]
19. Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Nishimaki H, Masuda S. Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer. Radiation Oncology 2017;12(1):16. [IF:2.862]
20. Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Matsui T, Watanabe M. Refractory Haematuria Resulting From Peritoneal Dissemination of Metastatic Gastric Cancer: Radiation Therapy For A Nodule Infiltrating The Urinary Bladder. Urology Journal 2017;14(1):2982-2984. [IF:0.88]
21. Ishibashi N, Maebayashi, Aizawa T, Sakaguchi M, Nakajima T, Kusumi Y. Definitive radiation therapy for an elderly Japanese patient with advanced clear cell adenocarcinoma PUBLICATION LIST 2017 Division of Radiology of the uterine cervix: a rare case report and review of the literature. International Journal of Clinical and Experimental Medicine 2017;10(7):11104-11108. [IF:0.833]
22. Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Saito T. Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy. Anticancer Research 2017;37(2):941-947. [IF:1.865]
